Michael Martin Breen is Executive Chairman/Interim CEO of GT Biopharma Inc.
Person profile
Roles
GT Biopharma
Executive Chairman/Interim CEO
Prairie Operating
Director
Address
Liphook, United Kingdom
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
11 Aug 23 | GTBP GT Biopharma | Common Stock | Grant | Acquire A | No | No | 0.287 | 200,000 | 57.40 k | 856,218 |
3 May 23 | PROP Prairie Operating | Common Stock | Grant | Acquire A | No | No | 0.175 | 218,571 | 38.25 k | 1,144,683 |
3 May 23 | PROP Prairie Operating | Common Stock | Buy | Acquire P | No | No | 0.109 | 916,112 | 99.86 k | 926,112 |
11 Apr 23 | GTBP GT Biopharma | Common Stock | Buy | Acquire P | No | No | 0.5 | 50,000 | 25.00 k | 656,218 |
27 Jan 23 | GTBP GT Biopharma | Option to purchase Common Stock Common Stock | Grant | Acquire A | No | No | 0.837 | 500,000 | 418.50 k | 500,000 |
3 Aug 20 | PROP Prairie Operating | Stock Option (Right to Buy Common Stock | Grant | Acquire A | No | No | 0.25 | 37,500 | 9.38 k | 67,500 |
12 Sep 19 | PROP Prairie Operating | Stock Option (Right to Buy Common Stock | Grant | Acquire A | No | No | 0.25 | 15,000 | 3.75 k | 30,000 |
16 Oct 18 | PROP Prairie Operating | Stock Option Common Stock | Grant | Acquire A | No | No | 0.25 | 15,000 | 3.75 k | 15,000 |